{
 "PrintNo":"S8991","Version":"A","Session":2023,"Chamber":"SENATE","BillType":"Senate",
 "Published":"2024-04-08T09:59:42.137516Z","Status":"IN_SENATE_COMM",
 "Committee":"Alcoholism And Substance Use Disorders",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-06-03","Committee":"Alcoholism And Substance Use Disorders"}],
 "Actions":[
  {"Text":"REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS","Date":"2024-04-08","Chamber":"SENATE"},
  {"Text":"AMEND AND RECOMMIT TO ALCOHOLISM AND SUBSTANCE USE DISORDERS","Date":"2024-06-03","Chamber":"SENATE"},
  {"Text":"PRINT NUMBER 8991A","Date":"2024-06-03","Chamber":"SENATE","Version":"A"}
 ],
 "Sponsors":[
  {"ID":1233,"Name":"Pete Harckham","Short":"HARCKHAM"},{"ID":1522,"Name":"Jake Ashby","Short":"ASHBY"},
  {"ID":1501,"Name":"Jeremy Cooney","Short":"COONEY"},{"ID":427,"Name":"Patrick M. Gallivan","Short":"GALLIVAN"},
  {"ID":1499,"Name":"Peter Oberacker","Short":"OBERACKER"}
 ],
 "Title":"Relates to the availability of opioid reversal agents",
 "Summary":"Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.",
 "LawSection":"Mental Hygiene Law","LawCode":"Amd ยง19.09, Ment Hyg L; amd ยง3309, Pub Health L",
 "ActClause":"AN ACT to amend the mental hygiene law and the public health law, in relation to the availability of opioid reversal agents",
 "SameAsPrintNo":"A8075-2023"
}